DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...
Yenssen Biotech opens international distributor recruitment for Dermlin wound healing series, Ulceloocin oral ulcer ...
PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS) (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform ...
Trinity Biotech plc, a biotechnology company specializing in human diagnostics and diabetes management, announced it has secured an additional $4 million in debt financing from Perceptive Advisors.
In today’s fiercely competitive biotech industry, managing tight margins and evolving regulatory environments present major challenges. Add increased risks from geopolitical tensions, growing ...
Legend Biotech Obtains Electroporation Technology License from MaxCyte Covering Cell-Based Therapies
MaxCyte granted Legend Biotech a non-exclusive worldwide license to use MaxCyte’s Flow Electroporation ® technology and ExPERT™ platform in connection with the research, clinical development, and ...
Trinity Biotech plc announced a significant step in its transformation plan by appointing Barclays Capital Inc. as its exclusive financial advisor. The company is shifting its focus to developing its ...
Bernhard running samples at the DARO lab at the BioTech Connector on the Nebraska Innovation Campus. Photo provided by DARO. DARO, a biotech startup in Lincoln centered around early disease detection ...
Two kernels, 100 years apart: One yielded 60 bushels per acre in 1927; the other topped 623. They look nearly identical on the outside, but a century of genetic innovation separates them under the ...
The American Seed Trade Association will be the lead advocate for crop biotechnology now that the Biotechnology Innovation Organization has eliminated its agriculture and environment section. ASTA was ...
This biotech firm develops therapies for rare pulmonary diseases, leveraging proprietary drug delivery technology in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results